Hikma Pharmaceuticals PLC hit a new 52-week high, surpassing its previous peak of £23.14, which the company achieved on ...

Hikma Pharmaceuticals PLC closed 2.88% short of its 52-week high of £23.60, which the company reached on February 13th.

Stock pickers are generally looking for stocks that will outperform the broader market. And the truth is, you can ...

Hikma Pharmaceuticals (LON:HIK – Free Report) had its price objective lifted by Berenberg Bank from GBX 2,400 ($29.74) to GBX 2,560 ($31.73) in a research note published on Wednesday morning, ...

London – M42, a global health leader powered by artificial intelligence (AI), and Hikma Pharmaceuticals PLC (Hikma), ...

London’s blue chip stocks suffered another dip on Friday as the pound added to recent gains. Some of the City’s key ...

PLC (LSE: HIK), a global pharmaceutical company, is set to announce its financial results for the year ending December 31, 2024, on Wednesday, February 26, 2025. The company will make a recording of ...

Billings, compares the state’s purchase of overdose reversal drugs like Narcan from companies that have contributed to the ...

Pharmaceutical Industry Analysis in Saudi ArabiaThe pharmaceutical industry analysis in saudi arabia is poised for significant expansion over the coming decade, according to a new report by Future ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...